Research field (3)：
Clinical pharmacy
, Pharmacology
, Pharmaceuticals - health and biochemistry
Research keywords (1)：
分子生物学
Research theme for competitive and other funds (1)：
2011 - 2013 Generation of immunotoxins with super-targeting mAb in the acute myelocytic leukemia
Papers (23)：
Yuji Sakuma, Sachie Hirai, Toshiyuki Sumi, Toshiro Niki, Miki Yamaguchi. Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells. Biochemical and biophysical research communications. 2023. 678. 84-89
Miki Yamaguchi, Sachie Hirai, Masashi Idogawa, Toshiyuki Sumi, Hiroaki Uchida, Naoki Fujitani, Motoko Takahashi, Yuji Sakuma. Junctional adhesion molecule 3 is a potential therapeutic target for small cell lung carcinoma. Experimental cell research. 2023. 426. 2. 113570-113570
Sachie Hirai, Masashi Idogawa, Toshiyuki Sumi, Miki Yamaguchi, Toshiro Niki, Yuji Sakuma. Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells. Biochemical and biophysical research communications. 2022. 630. 24-29
Miki Yamaguchi, Sachie Hirai, Masashi Idogawa, Hiroaki Uchida, Yuji Sakuma. Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations. Experimental cell research. 2022. 413. 2. 113078-113078
Yuji Sakuma, Sachie Hirai, Toshiyuki Sumi, Makoto Tada, Takashi Kojima, Toshiro Niki, Miki Yamaguchi. MCL1 inhibition enhances the efficacy of docetaxel against airway-derived squamous cell carcinoma cells. Experimental cell research. 2021. 406. 2. 112763-112763
